Test tubes are seen in front of a displayed Pfizer logo in this illustration taken, May 21, 2021. REUTERS\/Dado Ruvic\/Illustration<\/p>\n
(Reuters) - Pfizer Inc said on Thursday it was recalling all lots of its anti-smoking treatment, Chantix, due to high levels of cancer-causing agents called nitrosamines in the pills.<\/p>\n
The drugmaker paused distribution of the drug in June, and has already recalled a number of lots of the medicine so far.<\/p>\n
Pfizer asked wholesalers and distributors on Thursday to stop the use and distribution of the tablets immediately.<\/p>\n
The company said there was no immediate risk to patients<\/p>\n
taking Chantix, but advised them to consult with their health care provider to check the availability of alternative treatments.<\/p>\n
Chantix was approved by the FDA in May 2006 as a prescription medication to help adults aged 18 and over quit smoking and is typically used for 12 to 24 weeks.<\/p>\n
<\/p>\n
Continued here:<\/p>\n
Pfizer recalls all lots of anti-smoking drug over carcinogen presence - Reuters<\/a><\/p>\n","protected":false},"excerpt":{"rendered":" Test tubes are seen in front of a displayed Pfizer logo in this illustration taken, May 21, 2021. REUTERS\/Dado Ruvic\/Illustration (Reuters) - Pfizer Inc said on Thursday it was recalling all lots of its anti-smoking treatment, Chantix, due to high levels of cancer-causing agents called nitrosamines in the pills. The drugmaker paused distribution of the drug in June, and has already recalled a number of lots of the medicine so far Continue reading